F
Fennec Pharmaceuticals
FENC
6.26300
USD
-0.217
(-3.35%)
Market Closed
Volume
634
EPS
0
Div Yield
0
P/E
65
Market Cap
123,960,438
EV Maker Fisker Files for Bankruptcy
4 months ago
Stocks news
Novo Nordisk Surges in Profit and Sales
5 months ago
Stocks news
Title: Fennec Pharmaceuticals
Sector: Healthcare
Industry: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.